
N-Methylethylenediamine | CAS:109-81-9
N-Methylethylenediamine
- 名称:N-甲基乙二胺 | N-Methylethylenediamine
- CAS号:109-81-9
- 别名:1-Methylethylenediamine; 2-(Methylamino)ethanamine; 2-(Methylamino)ethylamine; N-Methyl-1,2-diaminoethane; N-Methyl-1,2-ethanediamine; N-Methyl-1,2-ethylenediamine
- 分子式:C3H10N2
- 分子量:74.12
- EINESC号:203-707-4
产品描述
物理化学性质
沸点 | 140-144 ºC (17 Torr)** |
---|---|
闪点 | 41.1±0.0 ºC, 计算值* |
密度 | 0.818±0.06 g/cm3 (20 º |
折射率 | 1.4453 (589.3 nm 13 ºC)*** |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.A Zembowicz et al.Proceedings of the National Academy of Sciences of the United States of America, 88(24), 11172-11176 (1991-12-15)
Electrochemical and peroxidase oxidation study of N'-hydroxyguanidine derivatives as NO donors.Tingwei Cai et al.Bioorganic & medicinal chemistry letters, 12(11), 1507-1510 (2002-05-29)
Efficient formation of nitric oxide from selective oxidation of N-aryl N'-hydroxyguanidines by inducible nitric oxide synthase.A Renodon-Cornière et al.Biochemistry, 38(15), 4663-4668 (1999-04-14)
Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.David Lefèvre-Groboillot et al.Biochemistry, 42(13), 3858-3867 (2003-04-02)
Oxidation of N-hydroxyguanidines by cytochromes P450 and NO-synthases and formation of nitric oxide.Daniel Mansuy et al.Drug metabolism reviews, 34(3), 593-606 (2002-09-07)
Oxidative denitrification of the antitumour drug hydroxyguanidine.S A Everett et al.Free radical biology & medicine, 24(1), 1-10 (1998-01-22)
Microperoxidase 8 catalysed nitrogen oxides formation from oxidation of N-hydroxyguanidines by hydrogen peroxide.Rémy Ricoux et al.European journal of biochemistry, 270(1), 47-55 (2002-12-21)
Microsomal formation of nitric oxide and cyanamides from non-physiological N-hydroxyguanidines: N-hydroxydebrisoquine as a model substrate.B Clement et al.Biochemical pharmacology, 58(3), 439-445 (1999-07-29)
N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.M Dambrova et al.Archives of biochemistry and biophysics, 377(1), 101-108 (2000-04-25)
N-hydroxyguanidines as new heme ligands: UV-visible, EPR, and resonance Raman studies of the interaction of various compounds bearing a C=NOH function with microperoxidase-8.D Lefevre-Groboillot et al.Biochemistry, 40(33), 9909-9917 (2001-08-15)
Novel substrates for nitric oxide synthases.Ming Xian et al.Bioorganic & medicinal chemistry, 10(9), 3049-3055 (2002-07-12)
Aromatic bis-N-hydroxyguanidinium derivatives: synthesis, biophysical, and biochemical evaluations.Amila Kahvedžić et al.Journal of medicinal chemistry, 56(2), 451-459 (2012-12-21)
Zembowicz, A., et al. British Journal of Pharmacology, 107, 1007-1007 (1992)
Oxidations of N(omega)-hydroxyarginine analogues and various N-hydroxyguanidines by NO synthase II: key role of tetrahydrobiopterin in the reaction mechanism and substrate selectivity.C Moali et al.Chemical research in toxicology, 14(2), 202-210 (2001-03-22)
Relationship between the structure of guanidines and N-hydroxyguanidines, their binding to inducible nitric oxide synthase (iNOS) and their iNOS-catalysed oxidation to NO.David Lefèvre-Groboillot et al.The FEBS journal, 272(12), 3172-3183 (2005-06-16)
1-(2-Mercaptobenzenesulfonyl)-3-hydroxyguanidines--novel potent antiproliferatives, synthesis and in vitro biological activity.Kamil Brożewicz et al.European journal of medicinal chemistry, 55, 384-394 (2012-08-16)
N-hydroxyguanidines as substrates of nitric oxide synthases.T Bill Cai et al.Current topics in medicinal chemistry, 5(7), 721-736 (2005-08-17)
Reaction of N-hydroxyguanidine with the ferrous-oxy state of a heme peroxidase cavity mutant: a model for the reactions of nitric oxide synthase.Alycen Pond Nigro et al.Archives of biochemistry and biophysics, 500(1), 66-73 (2010-03-30)
Metalloporphyrin catalyzed oxidation of N-hydroxyguanidines: a biomimetic model for the H2O2-dependent activity of nitric oxide synthase.G M Keseru et al.Bioorganic & medicinal chemistry letters, 10(15), 1775-1777 (2000-08-11)
The peptidylglycine alpha-amidating monooxygenase (PAM): a novel prodrug strategy for amidoximes and N-hydroxyguanidines?Dennis Schade et al.ChemMedChem, 4(10), 1595-1599 (2009-08-21)
Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase.Patrick Slama et al.Biochemical and biophysical research communications, 316(4), 1081-1087 (2004-03-27)
Alternative nitric oxide-producing substrates for NO synthases.Daniel Mansuy et al.Free radical biology & medicine, 37(8), 1105-1121 (2004-09-29)
N-Hydroxyguanidines oxidation by a N3S copper-complex mimicking the reactivity of Dopamine beta-Hydroxylase.Patrick Slama et al.Journal of inorganic biochemistry, 103(3), 455-462 (2009-01-31)
A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.Qingzhi Zhang et al.Chemical communications (Cambridge, England), 49(14), 1389-1391 (2013-01-17)
The novel binding mode of N-alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis.Huiying Li et al.Biochemistry, 41(47), 13868-13875 (2002-11-20)
Unusual oxidative chemistry of N(omega)-hydroxyarginine and N-hydroxyguanidine catalyzed at an engineered cavity in a heme peroxidase.J Hirst et al.The Journal of biological chemistry, 275(12), 8582-8591 (2000-03-18)
Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.M Veveris et al.British journal of pharmacology, 128(5), 1089-1097 (1999-11-11)
[Design, synthesis and antiasthmatic activities of NO-donating seratrodast derivatives].Zhi-guo Zhang et al.Yao xue xue bao = Acta pharmaceutica Sinica, 39(9), 705-710 (2004-12-21)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!